| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7301972 | Neuroscience & Biobehavioral Reviews | 2018 | 22 Pages |
Abstract
GFAP appears to be a promising blood biomarker for the prognosis and monitoring of mTBI, whereas UCH-L1 appears more promising at mTBI diagnosis. Despite this, the overall heterogeneity in assessed biomarkers, study design and measurement tools has made drawing specific conclusions challenging. Future research will require more uniform study design and methodological approaches to allow for the comparison, corroboration and validation of blood biomarkers within the context of paediatric mTBI.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Micaela Lugones, Georgia Parkin, Stefan Bjelosevic, Michael Takagi, Cathriona Clarke, Vicki Anderson, Vera Ignjatovic,